Fiber-Fed mice show promise against prostate cancer
NCT ID NCT06661044
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study from the University of Aberdeen looked at how dietary fiber supplements might influence prostate cancer. Researchers gave mice different fibers (inulin, pectin, hemp hull) along with stool samples from healthy men over 60. They then measured changes in gut bacteria and tumor growth. Only 6 volunteers provided samples, and the work was done in mice, not people.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dietary fiber supplements (inulin, pectin, hemp hull)
- What this could lead to
- If successful, this could point toward dietary fiber as a simple nutritional therapy to help manage prostate cancer.
- What could go wrong
- This is a very small, early-stage study in mice, not humans. Results may not translate to people, and the effect on tumors is uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
6 people
The number who actually took part.
- Started
-
Nov 2024
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The investigators will also invite men over 60 years who are staff at the University of Aberdeen, via All Staff mailing lists (including SMMSN and Rowett) and the University's weekly News Update and small ads.
- Ages
-
60 years and older
- Sex
-
Male participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Men (biologically male) over 60 years old. * Regularly pass a bowel motion at least daily. * Able to attend the Rowett Institute for consent procedure and able to arrange delivery of fresh faecal sample to the Rowett Institute on the required study day. Exclusion Criteria: * Living with cancer/on active cancer treatment. * Active ulcerative colitis or Crohn's disease. * Antibiotic therapy within previous 3 months. * Diarrhoea from recent foreign travel. * Known HIV or Hepatitis B positive. * Working directly on specific study for which samples are required. * Line managed or supervised by PI of study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Prostate cancer (adenocarcinoma) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Aberdeen
Aberdeen, Scotland, AB25 2ZD, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden bacteria in prostate tumors may shape how the immune system fights cancer
- Prostate tumors hide a Nerve-Fueled neighborhood, and scientists are mapping it
- A proactive care plan may help men with prostate cancer live better
- Can a simple blood test outsmart prostate cancer?
- A sharper eye on prostate cancer: could new imaging spare healthy tissue?
- Can a new drug combo tame resistant prostate cancer?